Latest filing published 30 Jun 2026 for HLS Therapeutics Inc., €26k.
No signal scores available.
All filings by Patricia Perry on record concern HLS Therapeutics Inc. The record holds 2 filings, for trades running from 5 May 2021 to 26 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 30 June 2026, the filings show a share grant worth €26k in HLS Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations